David Daniels, MD
General Practice · Columbia, TNNPI 1215916838
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 34.9% of the total. Reporting peaked in 2019 at $206 and has fallen 76.5% since, to $49 in 2025.
Across 42 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$256
- KCI USA, Inc.$93
- Smith+Nephew$87
- Organogenesis Inc.$71
- Kerecis Limited$51
- Aroa Biosurgery Incorporated$50
- plus $128 from 8 others
What the payments were for
- Food & beverage$735100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $256 |
| KCI USA, Inc. | 6 | $93 |
| Smith+Nephew | 6 | $87 |
| Organogenesis Inc. | 3 | $71 |
| Kerecis Limited | 2 | $51 |
| Aroa Biosurgery Incorporated | 2 | $50 |
| Convatec Inc. | 1 | $23 |
| Arteriocyte Medical Systems, Inc. | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Mckesson Patient Care Solutions Inc. | 1 | $14 |
| Medline Industries LP | 1 | $12 |
| Tactile Systems Technology Inc | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$735 in reported general payments places this provider in the 70th percentile of 1,632 general practice providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Hcl | 14 | $263 |
| Ciprofloxacin Hcl | 14 | $217 |
Paid to pharmacies, not to this prescriber.
Other general practice in Columbia
- Nathan GlennWinchester$874K
- Charles HooperChattanooga$158K
- Randall MontgomeryKingsport$92K
- Toluwalashe OnamusiNashville$80K
- Jonathon RogersGreeneville$60K
- Phillip KempBrentwood$50K
- Charles HooperChattanooga$38K
- Phillip TischbeinSmyrna$30K
- Joseph HolleyKnoxville$28K
- David ParkerKnoxville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.